Claris Advisors’s Dorman Products DORM Stock Holding History

Claris Advisors’s Portfolio DORM Stock Details DORM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2	Closed	-$226	–	365
2024 Q3	$226	Buy	+2	New	+$210	﹤0.01%	924

Other funds holding DORM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Claris Advisors's DORM Position: Q4 2024 in Review

Claris Advisors sold out of Dorman Products (DORM) in Q4 2024, closing a stake of 2 shares — an estimated $226 sold.

Claris Advisors first reported a position in DORM in Q3 2024 and held it in 1 quarter. The position peaked at $226 in Q3 2024. 339 funds tracked by Wall St. Rank hold DORM as of Q4 2024.

Claris Advisors reported no remaining Dorman Products position as of Q4 2024 after selling out during the quarter.
Claris Advisors sold 2 Dorman Products shares in Q4 2024, an estimated $226.
Claris Advisors first reported a position in Dorman Products in Q3 2024 and held it in 1 quarter.
Claris Advisors's Dorman Products position peaked at $226 in Q3 2024.
339 funds tracked by Wall St. Rank held Dorman Products as of Q4 2024.

Based on Claris Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.